We have received intimation from Mr. Akash Sethi (Promoter & Managing Director) pursuant to Regulation 29(2) of the SEBI (SAST) Regulations regarding acquisition of 1,65,355 Equity Shares ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 0.8 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mr. Akash Sethi, Promoter and Managing Director of Shree Pacetronix Limited, has acquired 1,65,355 equity shares of the company through an off-market transfer from Bio Pace Technology INC on March 20, 2026. This increased his holding from 3,13,416 shares (8.04% on diluted basis) to 4,78,771 shares (12.28% on diluted basis), a jump of about 4.24 percentage points. The disclosure is filed under Regulation 29(2) of SEBI (SAST) Regulations, 2011. The total equity share capital of the company remains 37,49,700 shares, with a fully diluted capital of 39,00,000 shares.
This is a positive signal for shareholders as it shows promoter confidence through an increase in personal stake. The promoter now holds a significantly larger chunk of the company, which may improve market sentiment. However, since the acquisition is close to the 5% creeping acquisition limit, further promoter purchases in the same financial year could attract SAST regulatory triggers.